On February 5, 2021, the board of directors, or the Board, of Apollo Endosurgery, Inc. appointed Charles McKhann as President and as a member of the Board, effective as of March 1, 2021. Mr. McKhann, previously served as Managing Director of Vernon Advisors, a healthcare advisory firm, from September 2012 to January 2021. From October 2017 to December 2018, Mr. McKhann served as Chief Commercial Officer of ROX Medical, Inc., a medical technology company. From July 2016 to April 2017, Mr. McKhann served as Chief Commercial Officer of Torax Medical, Inc., a medical technology company. From February 2015 to July 2016, Mr. McKhann served as Chief Commercial Officer of Intersect ENT, Inc., a medical technology company. The company also announced that the departure of Todd Newton as Director, each to be effective on or around March 1, 2021, or the Departure Date.